Success Story: From Phytochemical Research to Targeted Nanomedicine, NIW Approved for a Pharmaceutical Sciences Researcher

Posted by wegreened on September 22, 2026 in NIW, Pharmaceutical Sciences

Client’s Testimonial:

"Thanks again for your help throughout the case.”

On August 19^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Pharmaceutical Sciences (Approval Notice).

General Field: Pharmaceutical Sciences

Position at the Time of Case Filing: Graduate Research Assistant

Country of Origin: Bangladesh

State of Residence at the Time of Filing: Texas

Approval Notice Date: August 19^th, 2026

Processing Time: 3 months, 6 days (Premium Processing Requested)

Case Summary:

This NIW case told a story of clear scientific progression. The client’s foundational research into naturally derived therapeutics and responsive nanomaterials provided the direct technical basis for the client's proposed endeavor in targeted pharmaceutical delivery systems. Moving forward, the client planned to engineer advanced nanoparticle platforms specifically designed to treat severe chronic diseases. By developing responsive, highly targeted nanocarriers, this research aimed to overcome critical clinical limitations in drug stability and bioavailability, ultimately improving controlled therapeutic release and overall patient outcomes.

To demonstrate that the client was prepared to take this next step, North America Immigration Law Group (Chen Immigration Law Associates) documented an established record in pharmaceutical research. The evidence included 14 peer-reviewed journal articles, as well as 8 submitted journal articles. The client's published work had received 107 citations, but the significance of that record became clearer when evaluated against other research published during the same periods. Three papers ranked among the top 1% most cited articles for their respective publication years.

The case also demonstrated the practical impact of the client's findings within the broader scientific community. Other researchers actively drew upon the client's work in advanced material systems to design next-generation therapeutic delivery platforms. Furthermore, the client's experimental approaches for evaluating naturally derived compounds were used as foundational benchmarks in subsequent pharmacological research, while the client's analytical strategies directly informed later investigations into novel bioactive therapeutics. The record was further supported by funding from the Welch Foundation for research related to the proposed endeavor.

USCIS approved the petition on August 19th, 2026, after 3 months and 6 days of processing, with premium processing requested on June 23rd, 2026. For this case, the strongest narrative was the direction of the client's research itself: from evaluating bioactive compounds, to developing drug-delivery technologies, to pursuing advanced nanocarriers intended to make therapeutic compounds more stable, targeted, and effective. The NIW approval marks an important step as the client continues that progression in pharmaceutical sciences.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%